Have a personal or library account? Click to login
Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience Cover

Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience

Radiology and Oncology
Volume 55 (2021): Issue 4 (December 2021)
By: Martina Vrankar,  Karmen Stanic,  Stasa Jelercic,  Eva Ciric,  Ana Lina Vodusek and  Jasna But-Hadzic  
Open Access
|Nov 2021

Metrics

DOI: https://doi.org/10.2478/raon-2021-0044 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 482 - 490
Submitted on: Aug 19, 2021
|
Accepted on: Oct 7, 2021
|
Published on: Nov 19, 2021
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
non-small cell lung cancer,
stage III,
chemoradiotherapy,
durvalumab
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2021 Martina Vrankar, Karmen Stanic, Stasa Jelercic, Eva Ciric, Ana Lina Vodusek, Jasna But-Hadzic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 55 (2021): Issue 4 (December 2021)Next article